Suppr超能文献

吡罗昔康(FDDF)和萘普生钠的术后镇痛效果及安全性。

The postoperative analgesic efficacy and safety of piroxicam (FDDF) and naproxen sodium.

作者信息

Selçuk E, Gomel M, Apaydin S, Köse T, Tuglular I

机构信息

Ege University, Faculty of Dentistry, Department of Oral and Maxillofacial Surgery, Izmir, Turkey.

出版信息

Int J Clin Pharmacol Res. 1998;18(1):21-9.

PMID:9604731
Abstract

The aim of the present study was to compare the analgesic efficacy of piroxicam-FDDF (fast dissolving dosage form) with naproxen sodium, following bilateral removal of impacted third molars. A double-blind, randomized, crossover, analgesic trial was carried out on 40 patients undergoing surgical removal of one lower third molar at each visit. The analgesic efficacy of a single dose regimen of piroxicam-FDDF (40 mg, Feldene Flash, Pfizer, Turkey) was compared with naproxen sodium (550 mg, Anaprotab, Sanli, Turkey). Pain intensity was measured on a category-rating scale during the 8-h period after drug administration. Each patient evaluated the efficacy of the study medication at 15, 30, 45, 60, 90 and 120 min, and then hourly for up to 8 h of drug ingestion. Additional key efficacy measures were also determined (pain intensity difference [PID], sums of pain intensity difference [SPID], total pain relief [TOTPAR], peak pain relief, number of observations at which pain was half-relieved, overall evaluation of study medication effectiveness, and time to medication with a back-up analgesic). The data were analyzed by paired Student's t-test and one-way analysis of variance (ANOVA). Results are expressed as means +/- SEM, and p < 0.05 was taken as statistically significant. The PID and pain relief scores of the piroxicam-FDDF group were significantly greater than those for the naproxen sodium group at 15, 30, 45 and 60 min (p < 0.01). After 90 min to 8 h, no statistical significance was revealed among the two test groups (p > 0.05). The peak pain relief, maximal analgesic effect, SPID, TOTPAR values, adjusted mean number of observations with pain at least half-relieved, and the final overall evaluation records were all superior for piroxicam-FDDF (p < 0.05). The results of this study clearly show that the analgesic efficacy of piroxicam-FDDF is superior to naproxen sodium in the treatment of pain following oral surgery for the removal of impacted third molars.

摘要

本研究的目的是比较吡罗昔康速溶剂型(FDDF)与萘普生钠在双侧拔除阻生第三磨牙后的镇痛效果。对40例每次就诊时接受单侧下颌第三磨牙拔除手术的患者进行了一项双盲、随机、交叉镇痛试验。将吡罗昔康FDDF(40毫克,Feldene Flash,辉瑞公司,土耳其)单剂量方案的镇痛效果与萘普生钠(550毫克,Anaprotab,Sanli公司,土耳其)进行比较。在给药后的8小时内,采用分类评分量表测量疼痛强度。每位患者在15、30、45、60、90和120分钟时评估研究药物的疗效,然后每小时评估一次,直至服药8小时。还确定了其他关键疗效指标(疼痛强度差值[PID]、疼痛强度差值总和[SPID]、总疼痛缓解率[TOTPAR]、最大疼痛缓解率、疼痛缓解一半时的观察次数、研究药物有效性的总体评估以及使用备用镇痛药的时间)。数据采用配对学生t检验和单因素方差分析(ANOVA)进行分析。结果以平均值±标准误表示,p<0.05被视为具有统计学意义。在15、30、45和60分钟时,吡罗昔康FDDF组的PID和疼痛缓解评分显著高于萘普生钠组(p<0.01)。90分钟至8小时后,两个试验组之间未显示出统计学差异(p>0.05)。吡罗昔康FDDF的最大疼痛缓解率、最大镇痛效果、SPID、TOTPAR值、疼痛至少缓解一半的调整后平均观察次数以及最终总体评估记录均更优(p<0.05)。本研究结果清楚地表明,在拔除阻生第三磨牙的口腔手术后疼痛治疗中,吡罗昔康FDDF的镇痛效果优于萘普生钠。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验